Our results suggest that PCOS patients with excessive AMH levels may require a relatively high rFSH starting dose, although further prospective randomized studies are needed to identify tailored starting dose without placing them at unnecessary risk of OHSS. This evidence concerns the gene AMH and polycystic ovary syndrome.